Ahmad Al-Rifai
Overview
Explore the profile of Ahmad Al-Rifai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
134
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lazarus J, Al-Rifai A, Sanai F, Alghamdi A, Sharara A, Saad M, et al.
Liver Int
. 2022 Jun;
43 Suppl 1:116-123.
PMID: 35689428
Hepatitis D virus (HDV) infection is a global public health concern, especially because of its unique existence in the presence of hepatitis B virus infection. HDV infection is estimated to...
2.
Annese V, Nathwani R, Alkhatry M, Al-Rifai A, Al Awadhi S, Georgopoulos F, et al.
Therap Adv Gastroenterol
. 2022 Jan;
14:17562848211065329.
PMID: 34987611
Background: Inflammatory bowel diseases (IBD) are chronic, relapsing-remitting inflammatory conditions with a substantial negative impact on health-related quality of life and work productivity. Treatment of IBD has been revolutionized by...
3.
Alkhatry M, Al-Rifai A, Annese V, Georgopoulos F, Jazzar A, Khassouan A, et al.
World J Gastroenterol
. 2020 Dec;
26(43):6710-6769.
PMID: 33268959
Ulcerative colitis and Crohn's disease are the main entities of inflammatory bowel disease characterized by chronic remittent inflammation of the gastrointestinal tract. The incidence and prevalence are on the rise...
4.
Jones D, Al-Rifai A, Frith J, Patanwala I, Newton J
J Hepatol
. 2017 Aug;
55(3):737.
PMID: 28843947
No abstract available.
5.
Dyson J, Elsharkawy A, Lamb C, Al-Rifai A, Newton J, Jones D, et al.
Liver Int
. 2014 Nov;
35(5):1633-41.
PMID: 25363895
Background & Aims: Patients with primary sclerosing cholangitis (PSC) frequently highlight the impact of fatigue on their life quality. The study aims were to evaluate fatigue and its associations in...
6.
Ben-Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, et al.
J Crohns Colitis
. 2010 Dec;
4(2):194-8.
PMID: 21122505
Background And Aim: Limited data suggests that pseudomembranes are uncommon in patients with inflammatory bowel disease (IBD) and C. difficile associated disease (CDAD), but the reason for this is unknown....
7.
Jones D, Al-Rifai A, Frith J, Patanwala I, Newton J
J Hepatol
. 2010 Aug;
53(5):911-7.
PMID: 20800924
Background & Aims: Long-term outcome in primary biliary cirrhosis (PBC) remains unclear. Whilst response to ursodeoxycholic acid (UDCA) is associated with good outcome, this effect is not universal. Early data...
8.
Ben-Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, et al.
Clin Gastroenterol Hepatol
. 2009 Jun;
7(9):981-7.
PMID: 19523534
Background & Aims: Management of Clostridium difficile infection in patients with flaring inflammatory bowel disease (IBD) has not been optimized. We investigated the effects of combination therapy with antibiotics and...